NCT01126866View on ClinicalTrials.gov

Curative Resectability of Not Optimally Resectable Liver and/or Lung Metastases From Colorectal Carcinoma (CRC) Under Intensified Chemotherapy

PHASE2TerminatedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

March 31, 2011

Study Completion Date

June 30, 2011

Conditions
Colorectal Carcinoma
Interventions
DRUG

intensified chemotherapy (FOLFOXIRI/Bevacizumab)

intensified chemotherapy (FOLFOXIRI/Bevacizumab)

Trial Locations (1)

691220

NCT, Heidelberg

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Roche Pharma AG

INDUSTRY

collaborator

Pfizer

INDUSTRY

lead

National Center for Tumor Diseases, Heidelberg

OTHER